Sources
- Publication date
- 22 November 2024
- Author
- European Innovation Council and SMEs Executive Agency
The Intellectual Property Office of the Philippines (IPOPHL) lauded the Food and Drug Administration (FDA) for intercepting about P28 million worth of counterfeit medicines and health devices under its rigorous “Oplan Katharos” initiative.